Student Oral Presentations Session IV

Tuesday, April 25, 2023

4:00 PM – 5:30 PM GMT

Moderator(s)

Deborah Layton, PhD, FISPE

Director
PEPI Consultancy Limited
Southampton, England, United Kingdom
Claudia Bruno, BSc(hon) (she/her/hers)

PhD candidate
School of Population Health, University of New South Wales; Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway
Sydney, United States

Disclosure(s):

Deborah Layton, PhD, FISPE: No relevant disclosure to display

Claudia Bruno, BSc(hon): No financial relationships to disclose

Presentations:

4:00 PM – 5:30 PM GMT

Feasibility of post-authorization randomized controlled trials for conditionally authorized anticancer medicines - a multistakeholder perspective
Presenting Author: Christine C. van Hattem, MSc – Utrecht University
Author: Amos de Jong, Msc – Utrecht University
Author: Jolien S. de Groot, MD, PhD – Dutch Medicines Evaluation Board
Author: Lourens T. Bloem, PharmD, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
4:00 PM – 5:30 PM GMT

Review of studies evaluating the effectiveness of risk minimization measures assessed by the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency during 2016-2021
Presenting Author: Renske Grupstra (she/her/hers) – Utrecht University
Author: Thomas Goedecke, Dr. – European Medicines Agency
Author: Helga Gardarsdottir, PharmD, PhD, – Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University
4:00 PM – 5:30 PM GMT

Description of the delay in completion of studies that evaluate the effectiveness of additional risk minimization measures
Presenting Author: Sharon CM Essink, MSc (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands.
Author: Inge M. Zomerdijk – Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands.
Author: Sabine MJM Straus, MD, PhD – Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands. Department of Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands.
Author: Helga Gardarsdottir, PharmD, PhD, – Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University
Author: Marie Louise L. De Bruin, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
4:00 PM – 5:30 PM GMT

Pragmatic SIMEX-type method to correct for measurement error in time-varying prescription-based exposures
Presenting Author: Steve Ferreira Guerra – McGill University
Author: Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
Author: Michal Abrahamowicz, PhD – McGill University
4:00 PM – 5:30 PM GMT

Effect of COVID-19 vaccines on post-COVID cardiac and thromboembolic complications
Presenting Author: Núria Mercadé Besora (she/her/hers) – IDIAP Jordi Gol
Author: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
Author: Elena Roel, MD – Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
Author: Antonella Delmestri, PhD (she/her/hers) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
Author: Clara Prats, PHD (she/her/hers) – Universitat Politècnica de Catalunya
Author: Annika M. Jödicke, PhD (she/her/hers) – University of Oxford
Author: Martí Català Sabaté, PhD (he/him/his) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
4:00 PM – 5:30 PM GMT

Common comorbidities and COVID-19 mortality: an empirical comparison of primary care alone vs additional hospital data linkage for association analyses
Presenting Author: Junqing Xie, MBBS, MSc, DPhil – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
Author: Yaqing Gao, MPH – Oxford University
Author: Antonella Delmestri, PhD (she/her/hers) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
Author: Sara Khalid, PhD – Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
Author: Gary S. Collins, PhD – Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford
Author: Annika M. Jödicke, PhD (she/her/hers) – University of Oxford
Author: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University